Corporate Alliance

The IndoUSrare Corporate Alliance: Uniting life science leaders to drive equity, access, and innovation in rare disease care globally.

The IndoUSrare Corporate Alliance brings together biopharmaceutical, medical device, and life science companies engaged in rare disease research. These members share a commitment to fostering collaboration between industry and patient communities to promote equitable, affordable access to therapies for all individuals affected by rare diseases worldwide. Alliance membership reflects a dedication to IndoUSrare’s mission — to educate, empower, and advocate for rare disease patients across the United States, India, and globally by bridging gaps, accelerating diagnostics, and advancing therapeutic solutions.

Membership Pillars

Partnering across the life sciences industry to enhance access to rare disease treatments worldwide

Connect
Connect
Collaborate
Collaborate
Educate
Educate
Facilitate
Advocate
Advocate

Membership Objectives

Member resources, support, and leadership will be deployed across a diverse range of activities ranging from R&D, education, policy, and advocacy with a focus on a key barrier to patient access to medicines and therapies – the lack of health equity and access to rare disease therapies for patients in India and other LMIC countries.

IndoUSrare Corporate Alliance Members

Learn more about Corporate Alliance Membership Benefits

A global alliance of life science innovators advancing rare disease diagnostics and therapies through patient-industry collaboration